Literature DB >> 11794225

Do nonsteroidal antiinflammatory drugs reduce the risk of Alzheimer's disease?

J C Breitner, P P Zandi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11794225     DOI： 10.1056/NEJM200111223452110

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

Review 1.  Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies.

Authors:  Mahyar Etminan; Sudeep Gill; Ali Samii
Journal:  BMJ       Date:  2003-07-19

2.  Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache County Study.

Authors:  Majid Fotuhi; Peter P Zandi; Kathleen M Hayden; Ara S Khachaturian; Christine A Szekely; Heidi Wengreen; Ronald G Munger; Maria C Norton; Joann T Tschanz; Constantine G Lyketsos; John C S Breitner; Kathleen Welsh-Bohmer
Journal:  Alzheimers Dement       Date:  2008-04-21       Impact factor: 21.566

Review 3.  Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect.

Authors:  Marina Miguel-Álvarez; Alejandro Santos-Lozano; Fabian Sanchis-Gomar; Carmen Fiuza-Luces; Helios Pareja-Galeano; Nuria Garatachea; Alejandro Lucia
Journal:  Drugs Aging       Date:  2015-02       Impact factor: 3.923

Review 4.  Non-cholinergic strategies for treating and preventing Alzheimer's disease.

Authors:  P Murali Doraiswamy
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 5.  Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications.

Authors:  Barbara Sperner-Unterweger
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  Neuroinflammatory processes in Alzheimer's disease.

Authors:  Michael T Heneka; M Kerry O'Banion; Dick Terwel; Markus Peter Kummer
Journal:  J Neural Transm (Vienna)       Date:  2010-07-15       Impact factor: 3.575

Review 7.  Life course health development: an integrated framework for developing health, policy, and research.

Authors:  Neal Halfon; Miles Hochstein
Journal:  Milbank Q       Date:  2002       Impact factor: 4.911

8.  No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies.

Authors:  C A Szekely; R C Green; J C S Breitner; T Østbye; A S Beiser; M M Corrada; H H Dodge; M Ganguli; C H Kawas; L H Kuller; B M Psaty; S M Resnick; P A Wolf; A B Zonderman; K A Welsh-Bohmer; P P Zandi
Journal:  Neurology       Date:  2008-05-28       Impact factor: 9.910

Review 9.  Targeting innate immunity to protect and cure Alzheimer's disease: opportunities and pitfalls.

Authors:  Giulia Cisbani; Serge Rivest
Journal:  Mol Psychiatry       Date:  2021-04-14       Impact factor: 15.992

10.  Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study.

Authors:  David H Cribbs; Nicole C Berchtold; Victoria Perreau; Paul D Coleman; Joseph Rogers; Andrea J Tenner; Carl W Cotman
Journal:  J Neuroinflammation       Date:  2012-07-23       Impact factor: 8.322
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.